Emerging CAR-T therapies for T-cell lymphoma

2 Views
administrator
administrator
07/14/23

Emmanuel Bachy, MD, PhD, Lyon Sud Hospital Center, Lyon, France, outlines novel promising CAR-T therapies in development for the treatment of T-cell lymphoma, including a CAR-T directed against the constant fraction of the T-cell receptor (TCR) and an allogeneic product directed against CD70. This interview took place at the European Hematology Association (EHA) Congress 2022 held in Vienna, Austria.

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next